Clinical Trials Directory

Trials / Completed

CompletedNCT06968117

Exploration of Pregnant Women's Reluctance Toward COVID-19 Vaccination

Status
Completed
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
Centre Hospitalier de Gonesse · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers

Summary

This study aims to explore the reasons behind the reluctance of pregnant women to get vaccinated against COVID-19. With the ongoing pandemic, it has become essential to understand the concerns that women have regarding the COVID-19 vaccine, especially during pregnancy. Pregnant women are at a higher risk of severe complications from COVID-19, including premature birth, preeclampsia, and the need for intensive care.The goal of this research is to identify the barriers that prevent pregnant women from getting vaccinated, whether they are based on fears, misconceptions, or a lack of information. By understanding these concerns, healthcare providers can have better conversations with their patients and provide accurate, evidence-based information to help them make informed decisions about their health and the health of their unborn child.Through interviews and visual methods, the study seeks to gather valuable insights into the emotional and psychological aspects of vaccine hesitancy among pregnant women. These findings will help develop a tool to assist healthcare providers in addressing vaccine hesitancy effectively, ensuring that women are given all the necessary information to make the best decision for their health and the well-being of their baby.

Conditions

Timeline

Start date
2021-11-01
Primary completion
2023-01-01
Completion
2023-01-01
First posted
2025-05-13
Last updated
2025-05-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06968117. Inclusion in this directory is not an endorsement.